Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
22.33
-0.24 (-1.06%)
At close: Jul 19, 2024, 4:00 PM
23.30
+0.97 (4.34%)
Pre-market: Jul 22, 2024, 6:53 AM EDT

Bicycle Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2017
Revenue
41.6126.9814.4611.710.3913.8
Upgrade
Revenue Growth (YoY)
168.47%86.52%23.65%12.58%-24.72%93.40%
Upgrade
Gross Profit
41.6126.9814.4611.710.3913.8
Upgrade
Selling, General & Admin
62.3260.4349.5132.4429.214.56
Upgrade
Research & Development
159.15156.581.6144.8833.1525.54
Upgrade
Operating Expenses
221.47216.92131.1277.3262.3540.1
Upgrade
Operating Income
-179.86-189.95-116.65-65.62-51.96-26.3
Upgrade
Interest Expense / Income
3.283.263.342.980.460
Upgrade
Other Expense / Income
-16.7-14-5.76-0.12-0.684.56
Upgrade
Pretax Income
-166.44-179.21-114.24-68.48-51.73-30.86
Upgrade
Income Tax
1.731.46-1.52-1.66-0.72-0.25
Upgrade
Net Income
-168.16-180.66-112.72-66.82-51.01-30.61
Upgrade
Shares Outstanding (Basic)
433630251911
Upgrade
Shares Outstanding (Diluted)
433630251911
Upgrade
Shares Change
41.86%20.00%18.35%30.90%73.34%2416.82%
Upgrade
EPS (Basic)
-4.42-5.08-3.80-2.67-2.66-2.77
Upgrade
EPS (Diluted)
-4.42-5.08-3.80-2.67-2.66-2.77
Upgrade
Free Cash Flow
-85.93-63.56-105.1-16.82-18.99-30.17
Upgrade
Free Cash Flow Per Share
-2.02-1.79-3.54-0.67-0.99-2.73
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-432.25%-704.13%-806.56%-560.98%-500.10%-190.56%
Upgrade
Profit Margin
-404.14%-669.72%-779.35%-571.25%-490.95%-221.78%
Upgrade
Free Cash Flow Margin
-206.51%-235.61%-726.67%-143.83%-182.76%-218.59%
Upgrade
EBITDA
-156.52-169.4-107.21-64.09-50-29.9
Upgrade
EBITDA Margin
-376.15%-627.96%-741.26%-547.91%-481.23%-216.67%
Upgrade
Depreciation & Amortization
6.656.553.691.411.280.96
Upgrade
EBIT
-163.16-175.94-110.9-65.5-51.28-30.86
Upgrade
EBIT Margin
-392.12%-652.22%-766.76%-559.96%-493.52%-223.62%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).